NEOLEUKIN THERAPEUTICS INC

CUSIP: 64049K104 Class: COM

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 1,010,812 Value ($000) $839 Avg Close Range
Q1 2023
Shares 1,016,296 Value ($000) $711 Avg Close Range
Q4 2022
Shares 1,016,296 Value ($000) $517 Avg Close Range
Q3 2022
Shares 1,025,886 Value ($000) $657 Avg Close Range
Q2 2022
Shares 1,123,205 Value ($000) $1,157 Avg Close Range
Q1 2022
Shares 1,280,501 Value ($000) $2,407 Avg Close Range
Q4 2021
Shares 1,600,003 Value ($000) $7,712 Avg Close Range
Q3 2021
Shares 1,610,572 Value ($000) $11,644 Avg Close Range
Q2 2021
Shares 1,593,582 Value ($000) $14,709 Avg Close Range
Q1 2021
Shares 1,518,403 Value ($000) $18,692 Avg Close Range
Q4 2020
Shares 1,153,490 Value ($000) $16,265 Avg Close Range
Q3 2020
Shares 1,089,020 Value ($000) $13,069 Avg Close Range
Q2 2020
Shares 994,339 Value ($000) $16,506 Avg Close Range
Q1 2020
Shares 527,451 Value ($000) $6,002 Avg Close Range
Q4 2019
Shares 521,850 Value ($000) $6,429 Avg Close Range
Q3 2019
Shares 245,408 Value ($000) $699 Avg Close Range